<DOC>
	<DOCNO>NCT00997152</DOCNO>
	<brief_summary>The purpose study evaluate effect JTT-654 diabetes well safety , tolerability pharmacokinetics JTT-654 type 2 diabetic patient .</brief_summary>
	<brief_title>Efficacy Safety Study JTT-654 Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Have type 2 diabetes ; 2 . Body mass index ( BMI ) â‰¤ 45.0 kg/m2 ; 3 . Are either untreated respect hypoglycemic agent OR currently treat stable dose metformin alone . 1 . Females pregnant breastfeeding ; 2 . Known medical history presence type 1 diabetes pancreatitis , acute metabolic diabetic complication , presence unstable rapidly progress retinopathy , nephropathy neuropathy ; 3 . Acute coronary syndrome uncontrolled hypertension ; 4 . Does meet diet previous/concomitant medication restriction criterion , describe protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Diabetes</keyword>
</DOC>